Crinetics Pharmaceuticals, Inc.·4

Mar 2, 5:27 PM ET

Krasner Alan Seth 4

4 · Crinetics Pharmaceuticals, Inc. · Filed Mar 2, 2021

Insider Transaction Report

Form 4
Period: 2021-02-26
Krasner Alan Seth
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-02-26+125,000125,000 total
    Exercise: $15.29Exp: 2031-02-25Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 26, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION